Neuronal nitric oxide synthase inhibition and regional sympathetic nerve discharge: implications for peripheral vascular control

Respir Physiol Neurobiol. 2013 May 1;186(3):285-9. doi: 10.1016/j.resp.2013.02.021. Epub 2013 Feb 27.

Abstract

Neuronal nitric oxide (NO) synthase (nNOS) inhibition with systemically administered S-methyl-l-thiocitrulline (SMTC) elevates mean arterial pressure (MAP) and reduces rat hindlimb skeletal muscle and renal blood flow. We tested the hypothesis that those SMTC-induced cardiovascular effects resulted, in part, from increased sympathetic nerve discharge (SND). MAP, HR, and lumbar and renal SND (direct nerve recordings) were measured in 9 baroreceptor (sino-aortic)-denervated rats for 20min each following both saline and SMTC (0.56mg/kg i.v.). SMTC increased MAP (peak ΔMAP: 50±8mmHg, p<0.01) compared to saline. Lumbar and renal SND were not different between saline and SMTC conditions at any time (p>0.05). The ΔSND between saline and SMTC conditions for the lumbar and renal nerves were not different from zero (peak ΔSND, lumbar: 2.0±6.8%; renal: 9.7±9.0%, p>0.05 versus zero for both). These data support that SMTC-induced reductions in skeletal muscle and renal blood flow reported previously reflect peripheral nNOS-derived NO vascular control as opposed to increased sympathetic vasoconstriction.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology*
  • Animals
  • Blood Pressure / drug effects
  • Citrulline / analogs & derivatives
  • Citrulline / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Heart Rate / drug effects
  • Kidney / drug effects
  • Kidney / innervation
  • Lumbosacral Region
  • Male
  • Nitric Oxide Synthase Type I / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Nerves / drug effects
  • Spinal Nerves / physiology
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / physiology*
  • Thiourea / analogs & derivatives
  • Thiourea / pharmacology

Substances

  • Enzyme Inhibitors
  • Citrulline
  • Nitric Oxide Synthase Type I
  • Thiourea
  • S-methylthiocitrulline